GlaxoSmithKline Biologicals > The former Sächsisches Serumwerk, located in the heart of Dresden, Germany, was acquired in 1992 by British drugmaker SmithKline Beecham. In 2000, the company merged with Glaxo Wellcome and has operated the factory since 2008 as GlaxoSmithKline Biologicals. This plant manufactures the influenza vaccine called Influsplit SSW ® (trade name Fluarix®outside of Germany) which is distributed to nearly 70 countries worldwide. Since 1992, annual vaccine production capacity at the facility has grown from 2 million to 70 million syringes, helping to make GlaxoSmithKline Bio- logicals the third largest supplier of flu vaccine in the world. In fact, Glaxo SmithKline (GSK) was the first manufacturer licensed to produce the influen- za pandemic vaccine in Europe. > Obje

Join for free to read